FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040695632> ?p ?o ?g. }

• W2040695632 endingPage "23" @default.
• W2040695632 startingPage "17" @default.
• W2040695632 abstract "In the follow-up of melanoma patients, there is still a need for an optimal serum marker to discover recurrent disease at an early stage. Melanoma inhibitory activity (MIA) has been investigated as a serum marker for cutaneous melanomas. Although the prognosis for melanoma based on stage is generally good, the disease identified at later stages is associated with high levels of morbidity and mortality. The value of MIA testing in early-stage melanoma was the goal of this study. Five thousand three hundred and thirty-four MIA serum values from 1079 consecutive melanoma patients in stages I and II were obtained during routine follow-up at scheduled intervals. Sensitivity and specificity of MIA were calculated. The area under the receiver-operating characteristics curve and Somers' Dxy rank correlation were assessed. Metastasis occurred in 137 patients with a sensitivity of MIA testing of 67.6% in stage I and 65.6% in stage II patients. The specificity was 76.9% for stage I and 66.7% for stage II patients. The most reliable normal upper limit for MIA was redefined at 12.0 ng/ml, when compared with 8.8 and 15.0 ng/ml. Multivariate analysis revealed significantly more frequent false-positive values in elderly women and in men with an increased Breslow thickness. MIA adapted with a new cut-off level is then a useful serum marker even in the follow-up of not yet relapsed early-stage melanoma patients. In older women and in men with an increased tumor thickness, the higher rate of false-positive values should be considered before starting further diagnostics. Additional prospective studies to clarify the clinical combination with other serum markers seem promising." @default.
• W2040695632 created "2016-06-24" @default.
• W2040695632 creator A5010027826 @default.
• W2040695632 creator A5014830822 @default.
• W2040695632 creator A5015624855 @default.
• W2040695632 creator A5062462205 @default.
• W2040695632 creator A5065762235 @default.
• W2040695632 creator A5079346049 @default.
• W2040695632 creator A5085505750 @default.
• W2040695632 creator A5088721391 @default.
• W2040695632 date "2009-02-01" @default.
• W2040695632 modified "2023-10-03" @default.
• W2040695632 title "Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma" @default.
• W2040695632 cites W1211144252 @default.
• W2040695632 cites W1892164682 @default.
• W2040695632 cites W1989631510 @default.
• W2040695632 cites W1993759179 @default.
• W2040695632 cites W2027904175 @default.
• W2040695632 cites W2030868812 @default.
• W2040695632 cites W2037987950 @default.
• W2040695632 cites W2041288965 @default.
• W2040695632 cites W2045577764 @default.
• W2040695632 cites W2059555350 @default.
• W2040695632 cites W2066319491 @default.
• W2040695632 cites W2082683659 @default.
• W2040695632 cites W2092302539 @default.
• W2040695632 cites W2095265622 @default.
• W2040695632 cites W2114624491 @default.
• W2040695632 cites W2324299840 @default.
• W2040695632 doi "https://doi.org/10.1097/cmr.0b013e32831bc78c" @default.
• W2040695632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19104451" @default.
• W2040695632 hasPublicationYear "2009" @default.
• W2040695632 type Work @default.
• W2040695632 sameAs 2040695632 @default.
• W2040695632 citedByCount "23" @default.
• W2040695632 countsByYear W20406956322012 @default.
• W2040695632 countsByYear W20406956322013 @default.
• W2040695632 countsByYear W20406956322014 @default.
• W2040695632 countsByYear W20406956322015 @default.
• W2040695632 countsByYear W20406956322016 @default.
• W2040695632 countsByYear W20406956322017 @default.
• W2040695632 countsByYear W20406956322018 @default.
• W2040695632 countsByYear W20406956322021 @default.
• W2040695632 countsByYear W20406956322023 @default.
• W2040695632 crossrefType "journal-article" @default.
• W2040695632 hasAuthorship W2040695632A5010027826 @default.
• W2040695632 hasAuthorship W2040695632A5014830822 @default.
• W2040695632 hasAuthorship W2040695632A5015624855 @default.
• W2040695632 hasAuthorship W2040695632A5062462205 @default.
• W2040695632 hasAuthorship W2040695632A5065762235 @default.
• W2040695632 hasAuthorship W2040695632A5079346049 @default.
• W2040695632 hasAuthorship W2040695632A5085505750 @default.
• W2040695632 hasAuthorship W2040695632A5088721391 @default.
• W2040695632 hasConcept C121608353 @default.
• W2040695632 hasConcept C126322002 @default.
• W2040695632 hasConcept C142724271 @default.
• W2040695632 hasConcept C143998085 @default.
• W2040695632 hasConcept C146357865 @default.
• W2040695632 hasConcept C151730666 @default.
• W2040695632 hasConcept C2777658100 @default.
• W2040695632 hasConcept C2779013556 @default.
• W2040695632 hasConcept C2779134260 @default.
• W2040695632 hasConcept C2780212769 @default.
• W2040695632 hasConcept C2908643394 @default.
• W2040695632 hasConcept C502942594 @default.
• W2040695632 hasConcept C530470458 @default.
• W2040695632 hasConcept C58471807 @default.
• W2040695632 hasConcept C71924100 @default.
• W2040695632 hasConcept C86803240 @default.
• W2040695632 hasConcept C90924648 @default.
• W2040695632 hasConceptScore W2040695632C121608353 @default.
• W2040695632 hasConceptScore W2040695632C126322002 @default.
• W2040695632 hasConceptScore W2040695632C142724271 @default.
• W2040695632 hasConceptScore W2040695632C143998085 @default.
• W2040695632 hasConceptScore W2040695632C146357865 @default.
• W2040695632 hasConceptScore W2040695632C151730666 @default.
• W2040695632 hasConceptScore W2040695632C2777658100 @default.
• W2040695632 hasConceptScore W2040695632C2779013556 @default.
• W2040695632 hasConceptScore W2040695632C2779134260 @default.
• W2040695632 hasConceptScore W2040695632C2780212769 @default.
• W2040695632 hasConceptScore W2040695632C2908643394 @default.
• W2040695632 hasConceptScore W2040695632C502942594 @default.
• W2040695632 hasConceptScore W2040695632C530470458 @default.
• W2040695632 hasConceptScore W2040695632C58471807 @default.
• W2040695632 hasConceptScore W2040695632C71924100 @default.
• W2040695632 hasConceptScore W2040695632C86803240 @default.
• W2040695632 hasConceptScore W2040695632C90924648 @default.
• W2040695632 hasIssue "1" @default.
• W2040695632 hasLocation W20406956321 @default.
• W2040695632 hasLocation W20406956322 @default.
• W2040695632 hasOpenAccess W2040695632 @default.
• W2040695632 hasPrimaryLocation W20406956321 @default.
• W2040695632 hasRelatedWork W2040695632 @default.
• W2040695632 hasRelatedWork W2075114781 @default.
• W2040695632 hasRelatedWork W2170910559 @default.
• W2040695632 hasRelatedWork W2356105190 @default.
• W2040695632 hasRelatedWork W2393830862 @default.
• W2040695632 hasRelatedWork W2560061394 @default.

• next